PharmaGossipAtLast

  • Subscribe to our RSS feed.
  • Twitter
  • StumbleUpon
  • Reddit
  • Facebook
  • Digg

Wednesday, August 14, 2013

How to Cover Up Research Abuse and Intimidate Critics. By Carl Elliott

Posted on 1:40 PM by Unknown
Imagine that you lose your only son to suicide in a medical experiment. When you try to get his study records, the university refuses. When you file suit, the university argues successfully in court that it is "immune." Then it retaliates by filing a legal action against you, demanding that you pay the university $57,000 in legal costs. When you try to deliver a letter of complaint to the university president, his staff calls security guards and has you escorted out of the building.

Believe it or not, these are the actions taken by the University of Minnesota, where I teach medical ethics, against Mary Weiss, a 70-year-old retired postal worker from St. Paul.

The basic facts of the case were first reported in the St. Paul Pioneer Press. In late 2003, a psychiatric research team led by Dr. Stephen Olson, the head of the Schizophrenia Program at the University of Minnesota, used the threat of involuntary commitment to coerce Mary's mentally ill son, Dan Markingson, into a profitable, AstraZeneca-funded drug study -- the so-called CAFÉ study. Dan was signed up for the CAFÉ study over the objections of his mother, and despite the fact that he had been repeatedly judged mentally incompetent to make his own medical decisions.

For months, Mary tried desperately to get Dan out of the study, warning that he was danger of committing suicide, but her warnings were ignored. On April 23, 2004, she left a voice message with the study coordinator, asking, "Do we have to wait for him to kill himself or someone else before anyone does anything?" Three weeks later, Dan's body was discovered in the shower of a halfway house, his throat severed so violently that he was nearly decapitated. He had left a note that said, "I left this experience smiling."

In the years since Dan's suicide, the scandal has only worsened. It has become clear that Olson and his co-investigator on the study, Dr. Charles Schulz, had serious, unaddressed financial conflicts of interest from their work with the drug industry. In addition, documents unsealed in federal fraud litigation against the study sponsor, AstraZeneca, suggested that Schulz had been involved in manipulating research data. Last fall, the state Board of Social Work found that the study coordinator for the CAFÉ study, Jean Kenney, had falsified the initials of doctors on study records, had performed medical tasks far beyond her limited training, and had failed to warn Dan of new dangers of the study drugs.

Yet despite all of these alarm bells, the university has blocked every effort to look into the case, claiming that it has already been exonerated. As those claims have been subjected to further scrutiny, however, they have almost all fallen apart. (The one exception is an incompetent, deeply flawed inspection by a local FDA official, which found no wrongdoing.) In fact, according to the deposition of the University of Minnesota official in charge of research subject protection, the university never even investigated Dan's death. Let me repeat that to make sure it is clear: A subject in a psychiatric experiment committed suicide so violently that he nearly severed his head, and the university did not even think it was worth investigating.

The facts of this case are not a secret. In fact, the behavior of the University of Minnesota has generated international outrage. An editorial in the Medical Journal of Australia has compared the Markingson case to the Tuskegee syphilis study. A petition calling on Minnesota Governor Mark Dayton to investigate has gotten support from leading medical figures from all over the world, including the editor of The Lancet, a former editor of the British Medical Journal, the director of Public Citizen's Health Research Group, a former Health and Disability Commissioner of New Zealand and three former editors of the New England Journal of Medicine. In total, nearly 300 physicians, bioethicists and other scholars have called for an investigation.

This is not surprising. In the 23 years I have been teaching and writing about the ethics of medical research, I have never come across a case of abuse this outrageous. Nor have I ever encountered university officials so aggressive in stonewalling legitimate investigation and intimidating critics. Perhaps most alarming of all is the fact that these tactics have been so successful. Not a single person at the University of Minnesota has been disciplined. If a public university can get away with abuse this egregious, how can any of us have confidence that research subjects anywhere are being properly protected?


Carl Elliott, M.D., Ph.D., is a professor in the Center for Bioethics at the University of Minnesota and the author of White Coat, Black Hat and Better than Well. He wrote about the suicide of Dan Markingson in the August 2010 issue of Mother Jones magazine.
http://www.huffingtonpost.com/carl-elliott-md-phd/dan-markingson-suicide_b_3756420.html
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Posted in Clinical Trails, Clinical Trial, Dan Markingson, Dan Markingson Death, Mental Health | No comments
Newer Post Older Post Home

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Popular Posts

  • Beautiful Barcelona! - Gedeon Richter ruled in breach of ABPI code
    LYNNE TAYLOR Gedeon Richter (UK) has breached the Association of the British Pharmaceutical Industry (ABPI) Code of Practice, and has brough...
  • GlaxoChinaGate contd. - Bwaaa!
    China Drug Probe 'Unfair,' Euro Group Says Thu, 09/05/2013 - 8:30am Foreign companies believe they are unfairly being singled out fo...
  • Another day, another J&J recall ... Mold found in schizophrenia drug forces Johnson & Johnson recall
    By  Bloomberg News  on September 11, 2013 at 5:25 PM, updated  September 11, 2013 at 5:27 PM Johnson & Johnson has recalled 5,000 vials ...
  • AllTrials Update
    Dear Friends Support for AllTrials around the world is growing and we need to keep it that way as we reach some crucial debates. The Europea...
  • Hurrah!
    Press Release 11 September 2013 FOR IMMEDIATE RELEASE The HRA is now implementing its plans for ensuri...
  • Advertisement
    The book addresses, in great, evidence-based detail, a general system failure caused by widespread crime, corruption, bribery and impotent d...
  • Of pigs and penicillin
    Extended Withdrawal Needed to Avoid Penicillin G Residues News US - A minimum 51-day withdrawal is necessary if penicillin G is used in pigs...
  • The Lancet has formally retracted the Jikei Heart Study paper, originally published in 2007
    . The retraction had been widely anticipated for more than a month, after a series of news reports in Japan made it clear that the long-simm...
  • Wrigley holds off on caffeinated gum as FDA reviews caffeine
    By Melissa Healy 7:54 p.m. EDT, May 9, 2013 Less than a week after the Food and Drug Administration announced that it would investigate the ...
  • Petition by Professor David Healy - please sign if you agree
    Let us see Drug Data! Drug hazards are not “trade secrets”! Drug companies maximize the sales of new drugs by hyping their benefits while do...

Categories

  • Abbott (1)
  • alltrials (1)
  • alosetron (1)
  • AstraZeneca (1)
  • Baxter (1)
  • big pharma (2)
  • bribery (7)
  • Champix (1)
  • chantix (1)
  • china (7)
  • Clinical Trails (1)
  • Clinical Trial (1)
  • corruption (5)
  • Dan Markingson (1)
  • Dan Markingson Death (1)
  • diabetes (2)
  • Diovan (1)
  • EFPIA (1)
  • glaxo (11)
  • Glaxo China bribery corruption (1)
  • gsk (7)
  • hongbao (1)
  • insurance (1)
  • Januvia (1)
  • johnson and johnson (1)
  • Lotronex (1)
  • Mefloquine (1)
  • Mental Health (1)
  • Merck (2)
  • Novartis (1)
  • pancreas (1)
  • pfizer (1)
  • pharma (1)
  • pharmaceuticals (1)
  • PhRMA (1)
  • quetiapine (1)
  • Sanofi (2)
  • scandal (1)
  • seroquel (1)
  • side effects (1)
  • suvorexant (1)
  • ucb (1)
  • Valsartan (1)
  • Zaltrap (1)

Blog Archive

  • ▼  2013 (300)
    • ►  September (40)
    • ▼  August (70)
      • Europe's drug bills piling up for Chicago pharmas
      • China probes of Glaxo, Sanofi, others put big chil...
      • Hundreds of Fosamax lawsuits vs. Merck ordered rea...
      • How much Tylenol is too much?
      • Pill Pop Culture - Big Pharma might sue over Tee S...
      • Health experts critical of pharma industry's new t...
      • Idaho gets $28 million in drug price case
      • GlaxoChinaGate contd. - Behind the China Bribery S...
      • I thought this was a joke
      • The Sunshine Act Makes for Gloomy Sales Reps
      • GlaxoChinaGate contd. - British investigator 'admi...
      • Institutional Corruption and Pharmaceutical Policy
      • Why Drug Companies Don't Care What You Think About...
      • Press Conference Wednesday: In Wake of Controversy...
      • Danny defends the indefensible
      • Amgen Said to Be Near Deal to Buy Onyx BY MICHAEL ...
      • Healthcare group Fresenius warned over Puerto Rico...
      • GlaxoChinaGate contd. - Now Lilly join the party!
      • HipOpGate - J&J Said to Weigh $3 Billion Settlemen...
      • GlaxoChinaGate contd. Briton held in China arrest...
      • Merck needs to cut costs, says analyst
      • UK gives prescribing powers to physios/podiatrists
      • Corporate Whistleblower Center Urges Drug Industry...
      • First, Do No Harm: Financial Conflicts in Medicin...
      • GlaxoChinaGate contd. - All aboard the Botox gravy...
      • Physicians under the Influence: Social Psychology ...
      • GlaxoChinaGate contd. - GSK graft probe in China m...
      • Having a BBQ this weekend? What's in your steak?
      • An interview with Ray Moynihan
      • China to Launch Fresh Probe of Drug-industry Bribery
      • How to Cover Up Research Abuse and Intimidate Crit...
      • Don't pull
      • FDA Knew of Poor Drug Production Practices at Spec...
      • Li Li Gate contd. - Novartis Says Employee Allegin...
      • GlaxoChinaGate cont. - now the overcharging issues...
      • Desert Storm veteran claims boss called PTSD suffe...
      • ChinaGate latest. Novartis Saleswoman claims she w...
      • GlaxoChinaGate contd. - BBC reports on China drug ...
      • Purdue Pharma has privately identified about 1,800...
      • At Last! - U.S. Probes Use of Antipsychotic Drugs ...
      • So Big Pharma, how's your reputation management go...
      • Novartis Hit by Scandal Over Japanese Drug Studies...
      • INTERVIEW WITH BEN GOLDACRE by Tania Ahsan
      • Bringing home the Bacon: China probe into alleged ...
      • The AllTrials campaign calls for all past and pres...
      • Which Big Pharmas are taking an offshore tax vacat...
      • GlaxoChinaGate contd. - New Whistle-Blower Alleges...
      • GlaxoChinaGate contd. - An interview with Liu Xuebin
      • China fines six companies for price fixing: Xinhua
      • Medical Malpractice Payments Fell to Lowest Level ...
      • J&J's Nucynta probe expands scrutiny of industry m...
      • Patients suffer from drug industry’s chronic greed...
      • Abbott agrees to pay $12 million fine in China bab...
      • AllTrials - what's the latest?
      • Australian pharma fury at 492 drug price cuts - Ph...
      • GlaxoChinaGate contd. - The Real Implications of t...
      • J&J slapped with HHS subpoena on Nucynta marketing
      • GlaxoChinaGate contd. the cartoon
      • Come together and boycott J&J
      • Big Pharma’s placebo problem Rebranding drugs is a...
      • For Some Men, Propecia's Sexual Side Effects May B...
      • Psychiatrists: the drug pushers - by Will Self
      • GlaxoChinaGate contd. - Will Big Pharma have to dr...
      • GlaxoChinaGate contd. - GSK scandal dangles prospe...
      • Patients Should Beware When New Drug for Overactiv...
      • China nixes patent for Gilead HIV, hepatitis drug ...
      • India pulls GSK's Tykerb patent - by Kevin Grogan
      • GlaxoChinaGate contd. - Now French, US drugs drug ...
      • Now J&J must pay for price fixing in China
      • The Curious Case Of AstraZeneca v. ACE
    • ►  July (104)
    • ►  June (81)
    • ►  May (5)
Powered by Blogger.